NPTX1
protein-codingneuronal pentraxin 1, the group of Long pentraxins
Gene summary
NPTX1 is a member of the neuronal pentraxin gene family. Neuronal pentraxin 1 is similar to the rat NP1 gene which encodes a binding protein for the snake venom toxin taipoxin. Human NPTX1 mRNA is exclusively localized to the nervous system. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0859334
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0859334
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0000437
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0020380
Submitter: ClinGen
*NPTX1* was first associated with autosomal dominant cerebellar ataxia in 2022 (Coutelier M, et al., PMID: 34788392). The *NPTX1* gene is a member of the neuronal pentraxin family and encodes a long neuronal pentraxin protein. It has various cellular and synaptic functions including mediating the uptake of synaptic material and presynaptic toxins (PMID: 8884281). The reported phenotype is characterized by a slowly progressive gait ataxia, oculomotor apraxia and other eye movement abnormalities, and cerebellar atrophy on brain imaging. Other features may be present as well and onset is typically, but not always, in adulthood (PMID: 20301317). Four missense variants that have been reported in 8 probands across 3 publications (PMIDs: 34788392, 35285082, 35560436) are included in this curation. One variant, c.1165G>A (p.Gly389Arg), was reported in five of the probands, but was excluded as a founder variant after haplotype analysis was performed (PMID: 34788392). The mechanism of pathogenicity is unclear. This gene-disease relationship is supported by expression studies showing that this gene is expressed in the central nervous system, with highest expression in the cerebellum (PMIDs: 34788392, 32913098). In summary, there is presently limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date September 11, 2024 (SOP Version 10).
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NPTX1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002522.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | 2 | 6 | ||
| missense | 1 | 4 | 54 | 4 | 63 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 4 | 57 | 6 | 2 | 70 |
Highest pathogenic variant AF is 0.0000037183338
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002513.2 | 5 | MANE Select | |
| Ensembl | ENSP00000307549.4 | 5 | MANE Select | |
| Ensembl | ENSP00000511957.1 | 3 | Standard | |
| Ensembl | ENSP00000511957.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- chemical synaptic transmission
- central nervous system development
- axonogenesis involved in innervation
- regulation of postsynaptic neurotransmitter receptor activity
Molecular Function
- metal ion binding
Cellular Component
- plasma membrane
- transport vesicle
- neuron projection
- glutamatergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000306773
- Coding exons
- 5
- Length
- 10696
- Individuals with no LoFs
- 125684
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125688
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.87 | 168 | 252 | 0.668 | 0.0000134 | 2783 |
| Missense (PolyPhen) | 35 | 86.559 | 0.40435 | 931 | ||
| Synonymous | -0.0986 | 116 | 115 | 1.01 | 0.00000677 | 891 |
| Loss of Function | 3.03 | 3 | 16.1 | 0.186 | 6.93e-7 | 174 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000028 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in mediating uptake of synaptic material during synapse remodeling or in mediating the synaptic clustering of AMPA glutamate receptors at a subset of excitatory synapses. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.185
Intolerance Scores
- LoFtool
- 0.240
- RVIS EVS
- -0.29
- RVIS percentile EVS
- 33.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.838
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |